Puro Pharmaceutical has added 7 new varieties to the 2026 edition of the National Essential Medicines List.

According to information from Pu Luo Pharmaceuticals, on July 9th, the National Health Commission, the National Administration of Traditional Chinese Medicine, and the National Center for Disease Control and Prevention jointly issued the "National List of Essential Medicines," which will be implemented from September 1, 2026. This time, Pu Luo Pharmaceuticals added 7 new varieties to the national essential medicine list, covering areas such as antibiotics, antivirals, antiepileptics, antihypertensive drugs, and respiratory system treatments.